116 related articles for article (PubMed ID: 7871001)
1. A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder.
Lecrubier Y; Puech AJ; Azcona A; Bailey PE; Lataste X
Psychopharmacology (Berl); 1993; 112(1):129-33. PubMed ID: 7871001
[TBL] [Abstract][Full Text] [Related]
2. Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain.
Haus U; Varga B; Stratz T; Späth M; Müller W
Scand J Rheumatol Suppl; 2000; 113():55-8. PubMed ID: 11028833
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of tropisetron in primary fibromyalgia--a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group.
Färber L; Stratz T; Brückle W; Späth M; Pongratz D; Lautenschläger J; Kötter I; Zöller B; Peter HH; Neeck G; Alten R; Müller W
Scand J Rheumatol Suppl; 2000; 113():49-54. PubMed ID: 11028832
[TBL] [Abstract][Full Text] [Related]
4. Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial.
Rickels K; Mathew S; Banov MD; Zimbroff DL; Oshana S; Parsons EC; Donahue SR; Kauffman M; Iyer GR; Reinhard JF
J Clin Psychopharmacol; 2008 Apr; 28(2):235-9. PubMed ID: 18344738
[TBL] [Abstract][Full Text] [Related]
5. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
6. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients.
Färber L; Stratz TH; Brückle W; Späth M; Pongratz D; Lautenschläger J; Kötter I; Zöller B; Peter HH; Neeck G; Welzel D; Müller W;
Int J Clin Pharmacol Res; 2001; 21(1):1-13. PubMed ID: 11708570
[TBL] [Abstract][Full Text] [Related]
7. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
[TBL] [Abstract][Full Text] [Related]
8. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
[TBL] [Abstract][Full Text] [Related]
9. Efficacy trial of the 5-HT2 antagonist MDL 11,939 in patients with generalized anxiety disorder.
Sramek JJ; Robinson RE; Suri A; Cutler NR
J Clin Psychopharmacol; 1995 Feb; 15(1):20-2. PubMed ID: 7714223
[TBL] [Abstract][Full Text] [Related]
10. Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxiety.
Smith WT; Londborg PD; Blomgren SL; Tollefson GD; Sayler ME
J Clin Psychopharmacol; 1999 Apr; 19(2):125-31. PubMed ID: 10211913
[TBL] [Abstract][Full Text] [Related]
11. [Effects of an anti-emetic tropisetron capsule on QOL of patients with delayed nausea and vomiting induced by cancer chemotherapy. Group for Investigation of QOL Questionnaire for Anti-Emetics used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative Study].
Nukariya N; Kobayashi K; Ishihara Y; Yoneda S; Matsuda T; Yakushiji M; Yamakido M; Fukuoka M; Niitani H; Furue H
Gan To Kagaku Ryoho; 1996 May; 23(6):757-71. PubMed ID: 8645027
[TBL] [Abstract][Full Text] [Related]
12. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G; Beeské S; Stahl SM
J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia.
Späth M; Stratz T; Neeck G; Kötter I; Hammel B; Amberger CC; Haus U; Färber L; Pongratz D; Müller W
Scand J Rheumatol; 2004; 33(4):267-70. PubMed ID: 15370724
[TBL] [Abstract][Full Text] [Related]
16. Results of the intravenous administration of tropisetron in fibromyalgia patients.
Müller W; Stratz T
Scand J Rheumatol Suppl; 2000; 113():59-62. PubMed ID: 11028834
[TBL] [Abstract][Full Text] [Related]
17. Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study.
Bandelow B; Chouinard G; Bobes J; Ahokas A; Eggens I; Liu S; Eriksson H
Int J Neuropsychopharmacol; 2010 Apr; 13(3):305-20. PubMed ID: 19691907
[TBL] [Abstract][Full Text] [Related]
18. Tropisetron for postoperative nausea and vomiting in patients after gynaecological surgery.
Zomers PJ; Langenberg CJ; de Bruijn KM
Br J Anaesth; 1993 Nov; 71(5):677-80. PubMed ID: 8251279
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
20. Tropisetron for the prevention of postoperative nausea and vomiting in women undergoing gynecologic surgery.
Alon E; Kocian R; Nett PC; Koechli OR; Baettig U; Grimaudo V
Anesth Analg; 1996 Feb; 82(2):338-41. PubMed ID: 8561338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
